tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
LLY is currently covered by 16 analysts with an average price target of $1111.63. This is a potential upside of $122.51 (12.39%) from yesterday's end of day stock price of $989.12.
Eli Lilly and Company's activity chart (see below) currently has 743 price targets and 550 ratings on display. The stock rating distribution of LLY is 93.94% BUY, 1.52% SELL and 4.55% HOLD.
Analysts average stock forecasts to be materialized ratio is 90.4% with an average time for these price targets to be met of 277.23 days.
Highest price target for LLY is $1500, Lowest price target is $950, average price target is $1225.36.
Most recent stock forecast was given by TRUNG HUYNH from RBC on 25-Feb-2026. First documented stock forecast 11-Nov-2013.
Currently out of the existing stock ratings of LLY, 62 are a BUY (93.94%), 1 are a SELL (1.52%), 3 are a HOLD (4.55%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 17-Nov-2022
$1250
$264.92 (26.89%)
$1080
20 days ago
(25-Feb-2026)
13/14 (92.86%)
$207.85 (19.94%)
136
Buy Since 24-Jan-2022
$1313
$327.92 (33.29%)
$1290
1 months 12 days ago
(05-Feb-2026)
33/42 (78.57%)
$293.86 (28.83%)
201
Buy Since 15-Nov-2016
$1300
$314.92 (31.97%)
$1150
1 months 12 days ago
(05-Feb-2026)
33/35 (94.29%)
$280.86 (27.56%)
269
Buy Since 27-Feb-2020
$1205
$219.92 (22.33%)
$985
1 months 12 days ago
(05-Feb-2026)
17/18 (94.44%)
$185.86 (18.24%)
145
Buy Since 13-Mar-2023
$1280
$294.92 (29.94%)
$1200
1 months 12 days ago
(05-Feb-2026)
20/22 (90.91%)
$260.86 (25.60%)
136
What is LLY (Eli Lilly and Company) average time for price targets to be met?
Which analyst has the current highest performing score on LLY (Eli Lilly and Company) with a proven track record?
Which analyst has the most public recommendations on LLY (Eli Lilly and Company)?
Which analyst is the currently most bullish on LLY (Eli Lilly and Company)?
Which analyst is the currently most reserved on LLY (Eli Lilly and Company)?
